T/FIF, a New Plateau Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (756)	1/23/2002 8:26:25 PM
From: tuck	Read Replies (3) of 2243

>>Ubiquitin ligases...... I don't know much about them. If there are different ligases for regulatory proteins like CDKs (take note, apostrophe police!!), then it might make sense. If not, it seems like just another anti-cancer approach that will land us in "selective toxicity" land.<< Would the results turned up by this search indicate that there are different ligases for regulatory proteins like CDKs? medscape.com Probably just showing off my ignorance, and none of this is even preclinical. But Rigel claims it will be ready to file an IND in the summer. If that's so, might not we expect publication of preclinical data pretty soon? Which might support the stock? An EDGAR search reveals no large sellers yet. Granted, they just did a cheap secondary, but getting it done at all might be a good sign. In sum, wondering if we really have that much time to decide about these folks. My Mom owns a bit, and I'm thinking of getting back in, too. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next